Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ: MIRM · USD

$85.6

+0.06 (+0.1%)· Recorded snapshot

Market cap	5.6B
Revenue (ttm)	618.1M
Net income (ttm)	-860.2M
EPS (ttm)	-$15.3
Shares out	64.9M
Volume	397,414
Beta	0.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 618.1M
Net income (ttm): -860.2M
EPS (ttm): -$15.3
Market cap: 5.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-703

P25 -113.8P50 -46.5P75 -0.9

ROIC-9.1

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All MIRM indicators

Market & fundamental data

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001759425
Company name	Mirum Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	604749101
Earnings date	2026-11-03
Earnings time	amc
Employees	433
Employees change	84
Employees growth	24.07%
Enterprise value	$5.9B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2019-07-18
Is primary listing	Yes
Is SPAC	No
ISIN number	US6047491013
Last 10-K release date	2026-02-25
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$5.6B
Market cap category	Mid-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$85.62
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	MIRM
U.S. state	California
Website	https://www.mirumpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-17.91%
EV/Sales	9.53x
FCF / EV yield	-3.88%
FCF yield	-4.11%
Forward EV/Sales	7.87x
Forward P/S	7.43x
P/S ratio	9x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-15.57%
EBITDA margin	-11.37%
Gross margin	81.72%
Operating margin	-15.57%
Pretax margin	-138.75%
Profit margin	-139.18%
Profit per employee	$-2M
Revenue per employee	$1.4M
ROA	-6.79%
ROA (5Y)	-17.92%
ROCE	-11.7%
ROE	-702.97%
ROE (5Y)	-58.06%
ROIC	-9.07%
SBC / revenue	16.82%
Tax / revenue	0.43%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Gross profit growth	48.94%
Gross profit growth (Q)	39.79%
Gross profit growth 3Y	73.59%
Gross profit growth 5Y	114.98%
Net income growth years	2
Revenue growth	44.02%
Revenue growth (Q)	37.92%
Revenue growth (QoQ)	10.23%
Revenue growth 3Y	74.77%
Revenue growth 5Y	123.84%
Revenue growth quarters	17
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.5M
Depreciation and amortization	$25.9M
EBIT	$-96.2M
EBITDA	$-70.3M
EPS	$-15.34
FCF per share	$-3.52
Financing cash flow	$506.6M
Free cash flow	$-228.7M
Free cash flow minus SBC	$-332.7M
Gross profit	$505.1M
Income taxes	$2.7M
Investing cash flow	$-172.8M
Net borrowing	$672.4M
Net cash flow	$103.9M
Net income	$-860.2M
Operating cash flow minus SBC	$-331.2M
Operating income	$-96.2M
Revenue	$618.1M
Stock-based compensation	$103.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.32
Book value per share	$-0.16
Interest coverage	-7.16
Long-term assets	$408.7M
Long-term liabilities	$832.6M
Net cash (debt)	$-324.7M
Net cash / market cap	-5.84%
Piotroski F-Score	3
Property, plant and equipment	$14.3M
Shareholders' equity	$-10.4M
Tangible book value	$-257.8M
Tangible book value per share	$-3.98
Total assets	$1B
Total cash	$438.3M
Total debt	$762.9M
Total liabilities	$1.1B
WACC	6.88%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.7
Current assets	$636.3M
Current liabilities	$222.8M
Current ratio	2.86
Inventory turnover	4.64
Net working capital	$-22.4M
Quick ratio	2.62
Working capital	$413.5M
Working capital turnover	1.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-15.36%
Dividend yield	0%
Shareholder yield	-15.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$99.42
1D price change	0.07%
1M price change	-4.24%
1M total return	-4.24%
1W price change	0.98%
1W total return	0.98%
1Y price change	20.01%
1Y return CAGR	20.02%
1Y total return	20.01%
20-day SMA	$82.63
200-day SMA	$98.62
3M price change	-24.78%
3M total return	-24.78%
3Y price change	216.51%
3Y return CAGR	46.81%
3Y total return	216.51%
50-day SMA	$90.49
50-day SMA vs 200-day SMA	50under200
52-week high	$130.00
52-week high date	2026-07-09
52-week low	$63.23
52-week low date	2025-12-15
5Y price change	448.18%
5Y return CAGR	40.54%
5Y total return	448.18%
6M price change	-7.12%
6M total return	-7.12%
All-time high	$130.00
All-time high date	2026-07-09
All-time low	$6.51
All-time low date	2019-11-20
Average true range (ATR)	$3.60
Average volume	743.9K
Beta (1Y)	0.89
Beta (2Y)	0.77
Beta (5Y)	0.61
Change from 52-week high	-34.14%
Change from 52-week low	35.41%
Change from all-time high	-33.92%
Change from all-time low	1,218.9%
Change from open	-0.59%
Day's gap	0.67%
Dollar volume	$34M
High price	$86.28
Low price	$85.50
Monthly RSI	56.86
Open price	$86.13
Position in 52-week range	15.38%
Premarket change	0.33%
Premarket close	$85.56
Premarket price	$85.84
Previous close	$85.56
Price vs 150-day SMA	-13.6%
Price vs 20-day SMA	3.95%
Price vs 200-day SMA	-12.9%
Price vs 50-day SMA	-5.08%
Relative volume	0.53
Return from IPO open	559.08%
Return from IPO price	471.2%
RSI	50.61
Sharpe ratio	0.54
Sharpe ratio (3Y)	0.94
Sharpe ratio (5Y)	0.84
Sortino ratio	0.86
Sortino ratio (3Y)	1.58
Sortino ratio (5Y)	1.38
Volume	397.4K
Weekly RSI	43.77
YTD price change	8.75%
YTD total return	8.75%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	56.4M
Float percentage	86.84%
Shares change (QoQ)	7.69%
Shares change (YoY)	15.36%
Shares held by insiders	1.33%
Shares held by institutions	100.52%
Shares outstanding	64.9M
Short % of float	12.39%
Short % of shares	10.76%
Short ratio	9.7 days

Deeper analysis on MIRM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MIRM report

Is a complete MIRM research report available?

No complete published report is available for Mirum Pharmaceuticals, Inc. (MIRM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Mirum Pharmaceuticals, Inc. (MIRM)

Price

Financial snapshot

Fair-value bridge

Latest news · MIRM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MIRM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MIRM

Frequently asked questions